{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:19:12Z","timestamp":1789521552818,"version":"build-2803163510"},"reference-count":15,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Stroke Vasc Neurol"],"accepted":{"date-parts":[[2021,12,22]]},"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The rate of intravenous tissue plasminogen activator (IVtPA) administered to stroke mimics (SM) occurs in 24%\u201344% of telestroke series.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We reviewed 270 suspected acute ischaemic stroke (AIS) patients who were evaluated by telestroke and received IVtPA from 1 July 2016 to 30 September 2017 at our academic comprehensive stroke centre.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among 270 AIS patients who received IVtPA via telestroke, 64 (23.7%) were diagnosed with SM. Compared with patients who had a stroke, the SM group was younger (mean age 56.4 vs 68.2, p&lt;0.0001), more likely to be female (60.9% vs 45.6%, p=0.0324) and had longer door-to-needle times (85.3 vs 69.9, p=0.0008). The most common SM diagnoses were migraine 26 (40.6%), conversion disorder 12 (18.8%), encephalopathy 7 (10.9%) and unmasking (9.4%). Among the SM, migraine and conversion disorder were younger compared with the other subgroups (p&lt;0.001). Functional exam elements were noted more frequently in conversion disorder (66.7%) and migraine (34.6%), but rare in other diagnoses (p=0.006). Among the SM, 23 (35.9%) had a history of a prior similar episodes, and 15 (23.4%) had a history of more than 5 spells.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In our telestroke programme, 23.7% of those administered thrombolysis had a final diagnosis of SM.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/svn-2020-000776","type":"journal-article","created":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T12:00:17Z","timestamp":1643716817000},"page":"267-270","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["Thrombolysis of stroke mimics via telestroke"],"prefix":"10.1136","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8615-198X","authenticated-orcid":false,"given":"Vivien H","family":"Lee","sequence":"first","affiliation":[{"name":"Neurology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravyn","family":"Howell","sequence":"additional","affiliation":[{"name":"Neurology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randheer","family":"Yadav","sequence":"additional","affiliation":[{"name":"Neurology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Heaton","sequence":"additional","affiliation":[{"name":"Neurology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L","family":"Wiles","sequence":"additional","affiliation":[{"name":"Neurology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushil","family":"Lakhani","sequence":"additional","affiliation":[{"name":"Neurology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,2,1]]},"reference":[{"key":"2025081709325498000_7.3.267.1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.117.018758"},{"key":"2025081709325498000_7.3.267.2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.115.008650"},{"key":"2025081709325498000_7.3.267.3","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.111.000486"},{"key":"2025081709325498000_7.3.267.4","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000204041.13466.4c"},{"key":"2025081709325498000_7.3.267.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2011.09.012"},{"key":"2025081709325498000_7.3.267.6","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.111.000126"},{"key":"2025081709325498000_7.3.267.7","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181dad5a6"},{"key":"2025081709325498000_7.3.267.8","article-title":"Intravenous tissue plasminogen activator in stroke mimics findings from the get with the Guidelines\u2013Stroke registry","volume":"12","author":"Ali-Ahmed","year":"2019","journal-title":"Circulation: Cardiovascular Quality and Outcomes"},{"key":"2025081709325498000_7.3.267.9","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.115.009012"},{"key":"2025081709325498000_7.3.267.10","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1177\/1747493018790015","article-title":"Safety and predictors of stroke mimics in the Norwegian tenecteplase stroke trial (NOR-TEST)","volume":"14","author":"Kvistad","year":"2019","journal-title":"Int J Stroke"},{"key":"2025081709325498000_7.3.267.11","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181dbe0ad"},{"key":"2025081709325498000_7.3.267.12","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/STR.0000000000000211","article-title":"Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"key":"2025081709325498000_7.3.267.13","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.115.010613"},{"key":"2025081709325498000_7.3.267.14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1981.03320120022019"},{"key":"2025081709325498000_7.3.267.15","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000000122"}],"container-title":["Stroke and Vascular Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/svn-2020-000776","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T16:33:04Z","timestamp":1755448384000},"score":1,"resource":{"primary":{"URL":"https:\/\/svn.bmj.com\/lookup\/doi\/10.1136\/svn-2020-000776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,1]]},"references-count":15,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,6,24]]},"published-print":{"date-parts":[[2022,6]]}},"alternative-id":["10.1136\/svn-2020-000776"],"URL":"https:\/\/doi.org\/10.1136\/svn-2020-000776","relation":{},"ISSN":["2059-8688","2059-8696"],"issn-type":[{"value":"2059-8688","type":"print"},{"value":"2059-8696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,1]]}}}